Arne Melander

10.7k total citations
278 papers, 7.9k citations indexed

About

Arne Melander is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology and Mechanical Engineering. According to data from OpenAlex, Arne Melander has authored 278 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Endocrinology, Diabetes and Metabolism, 40 papers in Pharmacology and 39 papers in Mechanical Engineering. Recurrent topics in Arne Melander's work include Diabetes Treatment and Management (46 papers), Thyroid Disorders and Treatments (32 papers) and Diabetes Management and Research (27 papers). Arne Melander is often cited by papers focused on Diabetes Treatment and Management (46 papers), Thyroid Disorders and Treatments (32 papers) and Diabetes Management and Research (27 papers). Arne Melander collaborates with scholars based in Sweden, United States and Finland. Arne Melander's co-authors include Bengt Scherstén, F. Sundler, E. W�hlin-Boll, G. Sartor, E Wahlin‐Boll, U Westgren, Lars Ericson, Leif Groop, Ulf Lindblad and E. Wåhlin and has published in prestigious journals such as Nature, The Lancet and Annals of Internal Medicine.

In The Last Decade

Arne Melander

273 papers receiving 7.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arne Melander Sweden 49 2.7k 1.3k 941 936 894 278 7.9k
Ulrich Klotz Germany 59 320 0.1× 1.7k 1.2× 1.8k 1.9× 979 1.0× 2.1k 2.4× 349 14.2k
Paul Abrams United Kingdom 80 2.1k 0.8× 695 0.5× 1.0k 1.1× 1.0k 1.1× 8.8k 9.9× 454 39.1k
Markus van der Giet Germany 46 1.3k 0.5× 2.3k 1.7× 242 0.3× 1.0k 1.1× 1.8k 2.0× 253 9.6k
Lei Chen China 36 1.9k 0.7× 1.8k 1.3× 193 0.2× 738 0.8× 765 0.9× 215 6.5k
Mònica Bulló Spain 65 1.7k 0.6× 1.8k 1.4× 326 0.3× 4.0k 4.3× 820 0.9× 237 11.8k
Paul J. Taylor United Kingdom 44 973 0.4× 900 0.7× 658 0.7× 350 0.4× 1.1k 1.2× 220 6.4k
Junichi Sasaki Japan 52 2.8k 1.0× 2.6k 1.9× 352 0.4× 1.6k 1.7× 4.3k 4.8× 565 13.9k
Nathan W. Levin United States 81 1.8k 0.7× 1.8k 1.3× 355 0.4× 3.8k 4.0× 5.3k 6.0× 533 25.1k
Robert J. Williams United Kingdom 61 689 0.3× 4.0k 3.0× 1.3k 1.3× 2.1k 2.2× 2.1k 2.3× 271 14.5k
Giuseppe Ambrosio Italy 58 1.1k 0.4× 2.2k 1.7× 331 0.4× 1.7k 1.8× 2.3k 2.5× 410 14.1k

Countries citing papers authored by Arne Melander

Since Specialization
Citations

This map shows the geographic impact of Arne Melander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arne Melander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arne Melander more than expected).

Fields of papers citing papers by Arne Melander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arne Melander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arne Melander. The network helps show where Arne Melander may publish in the future.

Co-authorship network of co-authors of Arne Melander

This figure shows the co-authorship network connecting the top 25 collaborators of Arne Melander. A scholar is included among the top collaborators of Arne Melander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arne Melander. Arne Melander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nilsson, J. Lars G. & Arne Melander. (2006). Increased Introduction, Advertising, and Sales of Preventive Drugs During 1986–2002 in Sweden. Journal of Ambulatory Care Management. 29(3). 238–249. 6 indexed citations
2.
Andersson, Kristin, et al.. (2005). Repeat prescriptions: refill adherence in relation to patient and prescriber characteristics, reimbursement level and type of medication. European Journal of Public Health. 15(6). 621–626. 59 indexed citations
3.
Ohlsson, Henry, Ulf Lindblad, Thor Lithman, et al.. (2005). Understanding adherence to official guidelines on statin prescribing in primary health care—a multi-level methodological approach. European Journal of Clinical Pharmacology. 61(9). 657–665. 23 indexed citations
4.
Merlo, Juan, et al.. (2002). Bättre läkemedelsbehandling kan gynna folkhälsan en studie av möjliga läkemedelsinteraktioner i apoteksexpedieringar. Läkartidningen. 99(9). 5–922.
5.
Håkansson, Anders, et al.. (2001). Prescribing, prescription costs and adherence to formulary committee recommendations: long-term differences between physicians in public and private care. European Journal of Clinical Pharmacology. 57(1). 65–70. 22 indexed citations
6.
Jönsson, Anders, Bengt Hallengren, Tony Rydberg, & Arne Melander. (2001). Effects and serum levels of glibenclamide and its active metabolites in patients with type 2 diabetes. Diabetes Obesity and Metabolism. 3(6). 403–409. 26 indexed citations
7.
Lindberg, Gunnar, et al.. (1998). Use of calcium channel blockers and risk of suicide: ecological findings confirmed in population based cohort study. BMJ. 316(7133). 741–745. 49 indexed citations
8.
Melander, Eva, Sigvard Mölstad, Jonas Ranstam, et al.. (1998). Intra-urban variation of antibiotic utilization in children: influence of socio-economic factors. European Journal of Clinical Pharmacology. 54(8). 653–657. 25 indexed citations
9.
Rydberg, Tony, Anders Jönsson, M. O. Karlsson, & Arne Melander. (1997). Concentration-effect relations of glibenclamide and its active metabolites in man: modelling of Pharmacokinetics and Pharmacodynamics. British Journal of Clinical Pharmacology. 43(4). 373–381. 58 indexed citations
10.
Merlo, Juan, et al.. (1994). Age standardisation of drug utilisation: comparisons of different methods using cardiovascular drug data from Sweden and Spain. European Journal of Clinical Pharmacology. 46(5). 393–8. 17 indexed citations
11.
Groop, Per‐Henrik, Arne Melander, & Leif Groop. (1993). The relationship between early insulin release and glucose tolerance in healthy subjects. Scandinavian Journal of Clinical and Laboratory Investigation. 53(4). 405–409. 5 indexed citations
12.
Groop, Per‐Henrik, Arne Melander, & L. Groop. (1993). The Acute Effect of Preprandial Exogenous and Endogenous Sulphonylurea‐stimulated Insulin Secretion on Postprandial Glucose Excursions in Patients with Type 2 Diabetes. Diabetic Medicine. 10(7). 633–637. 4 indexed citations
13.
Karlberg, Mikael, Måns Magnusson, Rolf Johansson, Eva-Maj Malmström, & Arne Melander. (1992). Reduced Body Sway after Physiotherapeutic Treatment of Patients with Dizziness and Cervical Pain. Lund University Publications (Lund University). 1 indexed citations
14.
Melander, Arne, et al.. (1991). Anxiolytic-hypnotic drugs: Relationships between prescribing, abuse and suicide. European Journal of Clinical Pharmacology. 41(6). 525–529. 22 indexed citations
15.
Melander, Arne, Per-Olof Bitzén, O. K. Faber, & Leif Groop. (1989). Sulphonylurea Antidiabetic Drugs. Drugs. 37(1). 58–72. 82 indexed citations
16.
Luzi, Livio, et al.. (1989). HYPERGLYCAEMIA AND ABSORPTION OF SULPHONYLUREA DRUGS. The Lancet. 334(8655). 129–130. 73 indexed citations
17.
Sartor, G., et al.. (1987). Lack of primary effect of sulphonylurea (glipizide) on plasma lipoproteins and insulin action in former Type 2 diabetics with attenuated insulin secretion. European Journal of Clinical Pharmacology. 33(3). 279–282. 10 indexed citations
18.
Palmblad, Jan, Torbjörn Åkerstedt, Jan Fröberg, Arne Melander, & H. von Schenck. (1979). THYROID AND ADRENOMEDULLARY REACTIONS DURING SLEEP DEPRIVATION. European Journal of Endocrinology. 90(2). 233–239. 21 indexed citations
19.
Palmblad, Jan, L Levi, A Bürger, et al.. (1977). Effects of total energy withdrawal fasting on the levels of growth hormone thyrotropin cortisol adrenaline noradrenaline thyroxine tri iodo thyronine and reverse tri iodo thyronine in healthy males. Acta Medica Scandinavica. 20. 15–22. 3 indexed citations
20.
Melander, Arne & F. Sundler. (1972). Interactions between Catecholamines, 5-Hydroxytryptamine and TSH on the Secretion of Thyroid Hormone. Endocrinology. 90(1). 188–193. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ulrich Klotz Breakdown of academic impact, for papers by Paul Abrams Breakdown of academic impact, for papers by Markus van der Giet Breakdown of academic impact, for papers by Lei Chen Breakdown of academic impact, for papers by Mònica Bulló Breakdown of academic impact, for papers by Paul J. Taylor Breakdown of academic impact, for papers by Junichi Sasaki Breakdown of academic impact, for papers by Nathan W. Levin Breakdown of academic impact, for papers by Robert J. Williams Breakdown of academic impact, for papers by Giuseppe Ambrosio
Rankless by CCL
2026